Fabienne FOUFELLE,*t Nathalie LEPETIT,* Delphine BOSC,* Nathalie DELZENNE,* § Joelle MORIN,* Michel RAYMONDJEANt We have shown previously that fatty acid synthase (FAS) gene expression is positively regulated by glucose in rat adipose tissue and liver. In the present study, we have identified in the first intron of the gene a sequence closely related to known glucoseresponsive elements such as in the L-pyruvate kinase and S14 genes, including a putative upstream stimulatory factor/major late transcription factor (USF/MLTF) binding site (E-box) ( + 292 nt to + 297 nt). Location of this sequence corresponds to a site of hypersensitivity to DNase I which is present in the liver but not in the spleen. Moreover, using this information from a preliminary report of the present work, others have shown that a + 283 nt to + 303 nt sequence of the FAS gene can confer glucose responsiveness to a heterologous promoter. The protein binding to this region has been investigated in vitro by a
INTRODUCTION
We have shown previously in cultured adipose tissue of suckling rats that the fatty acid synthase (FAS) and acetyl-CoA carboxylase genes were responsive to glucose alone in a concentrationdependent manner and that glucose 6-phosphate could be the metabolite involved in this effect [1] . Insulin had no effect per se but was potentiating the glucose effect, probably by enhancing glucose metabolism. We have confirmed these data in the liver, showing that glucose was absolutely necessary for the induction of the FAS gene in cultured hepatocytes of suckling rats and that the role of insulin was indirect, probably by allowing the transcription ofthe glucokinase gene, thus enhancing the glucosephosphorylating capacity of the hepatocyte (C. Prip-Buus, D. Perdereau, F. Foufelle, P. Ferre and J. Girard, unpublished work). Actinomycin D totally blocks the glucose effect on the accumulation of FAS mRNA, showing that the glucose effect is transcriptional [2] . The same kind of glucose effect (through the generation of a glucose metabolite) has since been confirmed for the acetyl-CoA carboxylase and liver-type pyruvate kinase (L-PK) genes in a fl-pancreatic cell line [3, 4] .
For some other glucose-responsive genes, namely the L-PK (liver) and the S14 (liver, adipose tissue) genes, the DNA elements which determine glucose responsiveness (GIRE for Glucose Responsive Element) have been characterized [5] [6] [7] [8] [9] . They involve combination of DNase I footprinting and gel-retardation experiments with synthetic oligonucleotides and known nuclear proteins. DNase I footprinting experiments using a + 161 nt to + 405 nt fragment of the FAS gene demonstrate that a region from + 290 nt to + 316 nt is protected by nuclear extracts from liver and spleen. This region binds two ubiquitous nuclear factors, USF/MLTF and the CAAT-binding transcription factor/nuclear factor 1 (CTF/NF1). Binding of these factors is similar in nuclear extracts from liver which does or does not express the FAS gene as observed for glucose-reponsive elements in the L-pyruvate kinase and S14 genes. This suggests a posttranslational modification ofa factor ofthe complex after glucose stimulation.
a core sequence containing (1) a canonical (S14) or (2) a degenerated (L-PK) 5'-CACGTG-3' E-box, located from -172 nt to -143 nt in the L-PK gene and from -1457 nt to -1428 nt in the S14 gene, which bind a protein of the upstream stimulatory factor/major late transcription factor (USF/MLTF) family. Moreover, it has been shown recently that the flanking bases of the 5'-CACGTG-3' core are determinant for the glucose effect in the S 14 gene [8] . Since the original USF/MLTF sequence does not confer glucose responsiveness in the context of other promoters and since all available data suggest that the binding site for USF/MLTF family members is restricted to 5'-NNNC-ACGTGNNN-3', it has been suggested that protein-protein interaction between a USF/MLTF factor and an accessory factor may provide for specific regulation [8] .
A search in the FAS gene promoter has not revealed such a USF/MLTF consensus sequence. However, in the first intron of the FAS gene a 5'-CACGTG-3' sequence does exist, located from + 292 nt to + 297 nt. Using the information from a preliminary report of the present work, indicating that this element corresponded to a hypersensitive DNase I site, Towle's group has shown that a sequence + 283 nt to + 303 nt of the FAS gene confers glucose responsiveness (20-fold stimulation) in the context of a heterologous promoter [8] . The Nuclei were isolated from fresh tissues according to [10] . Isolated nuclei were suspended in 0.3 M sucrose, 60 mM KCI, 15 mM NaCl, 0.1 mM EGTA, 0.2 mM EDTA, 0.15 mM spermine, 0.5 mM spermidine, 15 mM Tris/HCl, pH 7.5, 5 % (v/v) glycerol, 0.5 mM dithiothreitol, 0.1 mM phenylmethanesulphonyl fluoride. They were stored at -80°C until required for use. Frozen nuclei were thawed and resuspended at a DNA concentration of 5 mg/ml, in the digestion buffer [60 mM KCl, 0. 1 mM EGTA, 5 % (v/v) glycerol, 15 mM Tris/HCl, pH 7.5, 0.5 mM dithiothreitol]. Nuclei were prewarmed (37°C for 10 min) and digestions were started by adding nuclei into tubes containing 5 mM MgCl2 and DNase I over a 1-8 /tg/ml range.
Control tubes contained MgCl2 but no DNase I. After 3 min of digestion at 37°C, the reaction was stopped by addition of the same volume of a buffer containing 150 mM NaCl, 15 mM EDTA, 0.3 % SDS and 50 mM Tris/HCl, pH 7.5.
Nuclei were incubated with RNase A (50,ug/ml) for 1 h at 37°C and then incubated overnight at 37°C with proteinase K (100 jug/ml). DNA was extracted twice with phenol/chloroform (1: 1, v/v) and precipitated with 4 vol. of 100 % ethanol for 1 h at -20 'C. After centrifugation and washing with 70 % ethanol, pellets were dissolved in 10 mM Tris/HCl, pH 7.5, containing 1 mM EDTA and the DNA was quantified spectrophotometrically at 260 nm and stored at -20 'C.
The samples were electrophoresed on a 1 % agarose gel. 35S-DNA mass markers were run in parallel. Blots were hybridized with a + 361 to + 656 probe labelled with [a-32P]dCTP using a random hexamer priming kit (Multiprime DNA labelling system, Amersham).
DNase I footprlnting
Nuclear extracts were prepared according to Gorski et al. [10] from isolated liver nuclei. The 245 bp fragment containing the FAS sequence from + 161 to + 405 was prepared in the following way. A double-stranded DNA fragment was synthesized by PCR from genomic liver DNA using as primers: 5'-TC-CTCAACAGCCCTGCGCTC-3' from + 161 nt to + 180 nt and 5'-ACCTCAAGCCACGGGGAAGC-3' from + 880 nt to + 861 nt. The (20-40, g ) and was incubated at + 4 'C for 10 min. DNase I digestions were performed by adding 1 1A of a solution containing DNase I (100-400 ng) in 1OmM Hepes, pH 7.6, 25 mM CaCl2 for 5 min at 4 'C. The digestions were terminated-by adding 80 ,1 of a stop buffer containing 20 mM Tris/HCl, pH 8.0, 20 mM EDTA, 250 mM NaCl, 0.5 % SDS, 1 ,ug ofherring sperm DNA and 10 ,ug ofproteinase K. Following 60 min of incubation at 45 'C, samples were extracted twice with phenol/chloroform and precipitated with 300 ,1 of 100 % ethanol and 5 #1 of 5 M NaCl. After centrifugation, the pellet was resuspended in 3 ,ul of 90 % formamide, 0.1 % xylene cyanol and 0.1 % Bromophenol Blue. Equal counts were loaded on a 6 % polyacrylamide/7 M urea sequencing gel. DNase I cleavage sites protected from digestion were identified using cleavage sequencing reactions of the same labelled fragments [11] .
Oligonucleotides
The following oligonucleotides were synthesized by Genset (Paris, France). In these sequences, the E-box, which corresponds to the consensus binding site of USF/MLTF, is indicated in bold characters and the nuclear factor 1 (NF1) consensus binding site(s) is underlined. Three fragments of 1.4-1.5 kb, 0.7-0.9 kb, 0.55-0.65 kb were clearly generated by increasing amounts of DNase I in liver nuclei (Figure 1) . A fourth one of 0.4 kb, although weak, was consistently found. These four fragments correspond to hypersensitive DNase I sites labelled HSS-1, HSS-2, HSS-3 and HSS-4 respectively. HSS-l is located approximately at -0.6 kb and is found with the same intensity in nuclei of weaned rat liver, a tissue which expresses the FAS gene, and in the nuclei of the liver of suckling rats or of the spleen, tissues which do not express FAS. HSS-2 encompasses a larger protected region around the transcription start site, a region which in addition to the TATA box contains an insulin response element [14] . The sensitivity of this site is higher in the nuclei of liver than in the nuclei of spleen. HSS-3 is located at + 0.25-0.35 kb, a region corresponding to the putative G1RE (+ 292) and is readily apparent only in the liver nuclei. The site is present in the liver of both suckling and weaned rats with a similar hypersensitivity. Similar characteristics are found for HSS-4 located at + 0.4 kb.
DNase I hypersensitivity experiments were also conducted using a BamHI/BamHI (-2729, +656) fragment probed with the same 32P-labelled probe (+361, +656). The same hypersensitive sites were detected (results not shown).
The GIRE DNA region is protected from DNase I digestion by nuclear extracts Using a probe spanning nucleotides + 160 to + 405 (coding strand and non-coding strand) of the FAS gene, one region was protected against the nucleolytic attack of DNase I by liver nuclear extracts. This region corresponds to nucleotides + 290 to + 316 on the non-coding strand (Figure 2 ) and + 291 to + 315 on mew-Mmalwo TI 524 F. Foufelle and others the coding strand (results not shown). The protected sequence 5'-GTCACGTGGGCGCCGCGCCAGCCGGGT-3' includes part of the sequence (underlined) which has been shown to confer glucose responsiveness to an heterologous promoter (S14) [8] and contains a canonical USF/MLTF E-box (bold characters). A similar footprint was observed in the liver and spleen (Figure  2a) , suggesting that the nuclear factors which bind to DNA are of the ubiquitous type. Finally, the nutritional status of the animal, suckling or weaned rats, did not modified the protected region (Figure 2b) . The protected region Including the putative GIRE binds at least two proteins The interaction of nuclear proteins with the protected region +290 to +316 was further investigated by gel-mobility-shift assays. A major protein-DNA complex was formed with the oligonucleotide FAS 1 (+ 285 to + 316) in the presence of liver nuclear extracts from weaned rats ( Figure 3a , lane 2). This complex was specific since it disappeared with an excess of the same unlabelled FAS 1 oligonucleotide (Figure 3a, lane 3) . Competition with a 30-fold excess of the Ad-MLTF oligonucleotide led to the partial, but not total, disappearance of the complex (Figure 3a, lane 4) . Competition was already maximal with a 5-fold excess of the Ad-MLTF oligonucleotide and did not increase further (results not shown). This suggests (1) that a factor of the USF/MLTF family is indeed part of the complex and (2) that another factor is binding in this region.
Concerning the second factor, examination of the sequence + 296 to + 310, 5'-TgGGC-N5-GCCAg-3' showed a similarity (capital letters) with the known consensus sequence for the ubiquitous factor CTF/NF1, TT/CGGA/C-N5-GCCAA [15] [16] [17] . We thus tried a competition experiment between FAS 1 oligonucleotide and a canonical adenovirus NFl oligonucleotide in a 30-fold excess. The complex partially disappeared ( Figure  3a , lane 5). Competition was already maximal with a 2.5-fold excess of the NFl oligonucleotide and did not increase further (results not shown). A competition experiment with both Ad-MLTF and NFl oligonucleotides led to the total disappearance of the complex (Figure 3a , lane 6), indicating that the second factor binding to the protected region was probably of the CTF/NF1 family.
Mutation of the recognition consensus sites for USF/MLTF and CTF/NF1
In order to confirm the respective roles of each nuclear factor in the formation of the complex, mobility-shift experiments were performed using mFAS 1 and FAS I M oligonucleotides mutated respectively on the USF/MLTF and CTF/NF1 recognition sites. When a gel-mobility-shift assay was performed using liver nuclear extracts and the FAS 1 oligonucleotide mutated on the E-box (mFAS 1), the complex formed was not competed with by an excess of Ad-MLTF oligonucleotide but was totally abolished by competition with an excess of NFl oligonucleotide ( Figure  3b) . Conversely, when a gel-mobility-shift assay was performed using liver nuclear extracts and the FAS 1 oligonucleotide in which the NFl recognition sequence 5'-GCCA-3' is mutated to 5'-AAAA-3' (FAS IM), the complex formed was not competed with by an excess of NFl oligonucleotide but was totally abolished by competition with an excess of Ad-MLTF oligonucleotide (Figure 3c ). These experiments confirm the respective roles of factors of the USF/MLTF and CTF/NF1 family in the formation of the complex. A competition with the S14 GIRE oligonucleotide, which in gelshift experiments binds exclusively a member of the USF/MLTF family [7, 8] , led to the total disappearance of the complex ( Figure  4 , lane 4). Conversely in a gel-mobility-shift assay with the S14 oligonucleotide, competition with an excess of the FAS 2 oligonucleotide led to the disappearance of the complex ( Figure  4 , lane 9). This shows that the S14 G1RE and FAS 2 oligonucleotide bind similar factors. Competition with the L4 oligonucleotide (glucose-responsive element) from the L-pyruvate kinase promoter at a 30-fold excess gave no competition with the FAS or S 14 oligonucleotide (Figure 4 , lanes 5 and 10), confirming that the affinity of the degenerated E-box of the L-PK gene for USF/MLTF factors is lower than a canonical one [9] . Concerning the binding sites for CTF/NF1, since the oligonucleotide FAS 2 contains the sequence 5'-TGGGC-3' but not the sequence 5'-GCCAG-3' it can also be concluded that the former sequence is not sufficient for CTF/NF1 binding whereas the latter is absolutely necessary. It can be pointed out that in the HSV thymidine kinase (tk) promoter a single sequence similar to the one present in the FAS gene, 5'-CGCCAG-3', is sufficient to bind NFl with a good affinity [15] .
Purffled USF/MLTF and CTF1 bind to FAS 1 ollgonucleotide We performed an experiment with 43 kDa USF/MLTF prepared by in vitro translation of its cDNA clone. A gel-mobility-shift assay using the FAS 1 oligonucleotide gave rise to the appearance of a complex in the presence of a translated USF lysate but not with the unprogrammed lysate (Figure 5a ). Moreover, a similar experiment performed with the oligonucleotide mFAS 1, mutated on the USF/MLTF recognition site, did not give rise to a complex (results not shown). We also performed an experiment with purified CTF1. Purified CTF1 gave rise to the appearance of a complex in a gel-mobility-shift assay when using the FAS 1 oligonucleotide (Figure 5b ) but not when using the oligonucleotide FAS IM mutated on the CTF/NF1 recognition sequence (Figure 5c ). FAS IM was, however, still able to bind USF/MLTF (Figure 5c ). Since the consensus binding sites of the USF/MLTF and CTF/NF1 factors could be partially overlapping on the FAS 1 sequence, we investigated whether binding of the factor of one family precludes the binding of the factor of the other family or whether they can bind on the same oligonucleotide. We performed a gel-mobility-shift assay using USF/MLTF prepared by in vitro translation and purified CTF1. Clearly, when both USF and CTF1 were added together, a heavier complex appeared ( Figure 6 , lanes 6 and 7) when compared with USF alone (lanes 2 and 3) or CTF1 alone (lanes 4 and 5) . This strongly suggests that the two factors are able to bind at the same time on the DNA sequence.
The bulk of these results thus demonstrates that as for the S14 and L-PK G1RE, a factor of the USF/MLTF family is involved in the complex formed with nuclear proteins of the FAS G1RE and that a second factor of the CTF/NF1 family is present.
DISCUSSION
The FAS gene is formed from 43 exons, of which the first and the last are non-coding, and 42 introns with a long (1200 bp) first intron. The promoter region has been sequenced up to -4860 bp [18, 19] . It been found which interacts with specific nuclear protein(s) from liver and adipocytes and confers insulin responsiveness (2-3-fold stimulation) in an adipocyte cell-line [14] . It must be pointed out that in adipose tissue or in the liver, we have found no direct effect of insulin on FAS gene expression, suggesting that this insulin responsiveness could be linked to a differentiation rather than a regulatory process. In the first intron, in addition to the putative glucose response element ( + 292), consensus sequences for a glucocorticoid ( + 61 1), progesterone ( + 908) and fat-specific element (FSE) (+ 1005) have been detected [18] . We have shown in the present work that two DNase I hypersensitive sites are present when using the nuclei of liver, an organ which expresses the FAS gene, with a greater sensitivity, than when using nuclei of the spleen, an organ which does not express the FAS gene. One (HSS-2) is located in the proximal region of the promoter, near the transcription start site, and the other one (HSS-3) is in the first intron, near the putative GIRE region. None of them is sensitive to the nutritional conditions. These results differ from those of Roder et al. [20] since they do not find any hypersensitive site in the first intron nor around the transcription start site. The reasons for these discrepancies are unclear at the present time. HSS-1 found in the present study, a site with similar DNase I hypersensitivity in liver and spleen, could, however, correspond to the HSi-l site in their study at -0.5 kb.
We have performed further studies in the region of the HSS-3 site and we have shown that nuclear proteins bind to a sequence which includes an element conferring glucose responsiveness to an heterologous promoter (S14) [8] . Indeed, a region protected by nuclear extracts from DNase I in footprint experiments (+290 to +316) is able to bind concomitantly USF/ MLTF and CTF/NF1 factors. These factors are ubiquitous and it explains that similar footprints are found with nuclear extracts from liver and spleen.
We have now obtained evidence to think that we have indeed identified the GIRE of the FAS gene. First, this element is present in a region hypersensitive to DNase I in a FAS-expressing tissue but not in a tissue which does not express FAS (spleen). Secondly, when inserted in an heterologous promoter, it confers glucose responsiveness [8] . Thirdly, it binds a factor of the USF/MLTF family, a striking similarity with the L-PK and S14 G1RE. Final evidence should stem from transfection experiments using the FAS gene itself.
As described for the L-PK and S14 G1RE [7, 9, 21] , there was no qualitative or quantitative differences in the DNA-protein complex formed with nuclear extracts from suckling or weaned rats (present study) or from fasted and refed adult rats (results not shown), suggesting a post-translational modification of one factor of the complex after glucose stimulation. A recent study [22] suggests that a phosphorylation/dephosphorylation mechanism could be involved in the glucose signalling pathway of the S14 gene. Nevertheless, it is also possible that a protein which is part of the complex in vivo cannot be detected in the in vitro conditions used and it has been suggested for the G1RE that protein-protein interaction between a USF/MLTF factor and an accessory factor may provide for specific regulation [8] .
Could NFl have a role in this context? The S14 oligonucleotide which confers glucose responsiveness to a heterologous promoter does not bind other factors than USF/MLTF in gel-shift assays [7, 8] . However, comparison of the DNase I-protected G1RE regions of the S14 and FAS genes which contain only one E-box, shows that whereas it extends 5' of the 5'-CACGTG-3' core for S14, it extends on the 3' end in the FAS gene [7] . This suggests that in addition to the binding of an MLTF nuclear factor, binding of another factor might also be involved in the protection of this region in the S14 gene. It has been indeed shown in footprint experiments that for the S14 gene, competition with Ad-MLTF oligonucleotide does maintain a footprint on the -1440 to -1457 sequence. Interestingly enough, at the 5' end of the S14 G1RE, a sequence from -1449 to -1444, 5'-TGCCAG-3' (coding strand) is present in a position corresponding to a footprint which was not competed with by Ad-MLTF [8] . When this sequence is mutated, the glucose effect on a shortened S14 promoter is decreased [8] . The same sequence binds a factor of the CTF/NF1 family in the promoter of the human ,-globin [15] . Whether it also corresponds to a true NFl-binding site not detected in gel-shift experiments remains to be determined.
The FAS oligonucleotide + 283 5'-GGCCGCTGTCACG-TGGGCGCC-3' + 303 which confers the glucose responsiveness to a heterologous promoter [8] does not contain the recognition site +306 5'-GCCAG-3' +310 for NFl. This would tend to suggest that a member of the NFl family is not necessary for the glucose effect. However, the construction used to test the FAS sequence [8] contains a putative NFl binding site (5'-TGCCAA-3') situated 20 nt downstream of the FAS oligonucleotide and a site 5'-TTGGCGTCCTGTCAAT-3' 230 nt downstream of the FAS oligonucleotide for which the binding of a factor of the CTF/NF1 family has been shown [23] . Thus, a possible role for NFl in the context of the FAS promoter still remains a matter of debate.
Association of USF/MLTF in a G1RE with another nuclear factor is reminiscent of the situation seen for the L-PK G1RE in which an association between USF/MLTF and HNF4 is necessary in order to obtain the full responsiveness to glucose [5] .
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